Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-PATH HOLDINGS, INC.BPTH · Entity 9692 | Director | March 28, 2019 | April 01, 2019 |
| Vaxart, Inc.AVIR · Entity 6654 | Chief Financial Officer | April 03, 2017 | April 05, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-PATH HOLDINGS, INC.
Report date March 28, 2019 · Filed April 01, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.40 · Expires 2029-03-28 | Direct | 1,000 |
Reported balance
After 2019-03-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-03-28 · Grant · Acquired 1,000 · Balance 1,000 F1: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 1,000 shares, based on continuing service to Bio-Path Holdings, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 1,000 shares, based on continuing service to Bio-Path Holdings, Inc.
Vaxart, Inc.
Report date April 03, 2017 · Filed April 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.66 · Expires 2027-04-03 | Direct | 775,000 |
Reported balance
After 2017-04-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-04-03 · Grant · Acquired 400,000 · Balance 775,000 F1: This stock option vests as follows: 33% of the total stock option vests six (6) months after the grant date, on October 3, 2017 and the remainder of the stock option vests in equal monthly installments beginning November 3, 2017 to April 3, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: This stock option vests as follows: 33% of the total stock option vests six (6) months after the grant date, on October 3, 2017 and the remainder of the stock option vests in equal monthly installments beginning November 3, 2017 to April 3, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2019 Filed Apr 1, 2019 20:49 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001007382-19-000005 · primary_doc.xml · derivative · entry 1 COLONNESE MARK P · CIK 0001040766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 1,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 17:18 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001599765-18-000003 · primary_doc.xml · derivative · entry 1 COLONNESE MARK P · CIK 0001040766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-04-17 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 20,000 shares vesting on the first anniversary of April 17, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 20,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| July 13, 2017 Filed Jul 17, 2017 16:22 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001603963-17-000003 · primary_doc.xml · derivative · entry 1 COLONNESE MARK P · CIK 0001040766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-07-13 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of July 13, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 17:09 UTC | Vaxart, Inc. AVIR · Entity 6654 | GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.66 Strike: $0.66 | $262,400.00 |
DisclosureSEC source: 0001437749-17-006118 · rdgdoc.xml · derivative · entry 1 COLONNESE MARK P · CIK 0001040766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,000 Underlying: Common Stock · 400,000 shares Expires 2027-04-03 F1 · derivative.exercise_date: This stock option vests as follows: 33% of the total stock option vests six (6) months after the grant date, on October 3, 2017 and the remainder of the stock option vests in equal monthly installments beginning November 3, 2017 to April 3, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.